SHH:688336

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd · SHH · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:46 UTC

Last close

n/aCNY

Market data

7.1xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
69.0%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
66.5%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
0.4%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed

6 of 6 traits placed on the market's range. Nothing sits below its sector's middle.

Follow one yuan

lens 1 of 9

After what it costs to make

92.1%

After running the business

75.2%

After interest and tax

69.1%

After what it must reinvest

66.5%

Kept after the dividend

64.6%

after what it costs to make, 92.1% of sales; after running the business, 75.2% of sales; after interest and tax, 69.0% of sales; after what it must reinvest, 66.5% of sales; kept after the dividend, 64.6% of sales

The five stops

5 of 5 read

After what it costs to make3,866,165,87592.1%
After running the business3,157,397,54675.2%
After interest and tax2,899,304,58669.1%
After what it must reinvest2,790,507,20066.5%
Kept after the dividend2,714,051,10064.6%

Of every unit of sales, 0.65 is still there after the dividend.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales4,199,118,365
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
After what it costs to make3,866,165,875
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
After running the business3,157,397,546
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
After interest and tax2,899,304,586
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
After what it must reinvest2,790,507,200
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Kept after the dividend2,714,051,100
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY